AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
Article
May 5, 2021
Letter to the Editor

Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age

Tommaso Ballarini, PhD https://orcid.org/0000-0001-7299-5973, Debora Melo van Lent, PhD, Julia Brunner, MSc, Alina Schröder, MSc, Steffen Wolfsgruber, PhD, Slawek Altenstein, Dipl-Psych, Frederic Brosseron, PhD https://orcid.org/0000-0003-3137-7516, … Show All … , Katharina Buerger, MD, Peter Dechent, PhD, Laura Dobisch, MSc, Emrah Düzel, MD, Birgit Ertl-Wagner, MD, Klaus Fliessbach, MD, Silka Dawn Freiesleben, MSc, Ingo Frommann, Dipl-Psych https://orcid.org/0000-0002-7244-2014, Wenzel Glanz, MD, Dietmar Hauser, Dipl-Psych, John Dylan Haynes, PhD, Michael T. Heneka, MD, Daniel Janowitz, MD, Ingo Kilimann, MD, Christoph Laske, MD, Franziska Maier, MD, Coraline Danielle Metzger, MD, Matthias H. Munk, MD, Robert Perneczky, MD https://orcid.org/0000-0003-1981-7435, Oliver Peters, MD, Josef Priller, MD, Alfredo Ramirez, MD https://orcid.org/0000-0003-4991-763X, Boris-Stephan Rauchmann, MD, Nina Roy, PhD, Klaus Scheffler, PhD https://orcid.org/0000-0001-6316-8773, Anja Schneider, MD, Annika Spottke, MD, Eike Jakob Spruth, MD, Stefan J. Teipel, MD, Ruth Vukovich, MD, Jens Wiltfang, MD, Frank Jessen, MD, and Michael Wagner, PhD https://orcid.org/0000-0003-2589-6440 on behalf of the DELCODE Study GroupAuthors Info & Affiliations
June 15, 2021 issue
96 (24) e2920-e2932
https://doi.org/10.1212/WNL.0000000000012067
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

Objective

To determine whether following a Mediterranean-like diet (MeDi) relates to cognitive functions and in vivo biomarkers for Alzheimer disease (AD), we analyzed cross-sectional data from the German DZNE-Longitudinal Cognitive Impairment and Dementia Study.

Method

The sample (n = 512, mean age 69.5 ± 5.9 years) included 169 cognitively normal participants and individuals at higher AD risk (53 with relatives with AD, 209 with subjective cognitive decline, and 81 with mild cognitive impairment). We defined MeDi adherence according to the food frequency questionnaire. Brain volume outcomes were generated via voxel-based morphometry on T1-MRI, and cognitive performance was assessed with an extensive neuropsychological battery. AD-related biomarkers (β-amyloid42/40 [Aβ42/40] ratio, phosphorylated tau 181 [pTau181]) in CSF were assessed in n = 226 individuals. We analyzed the associations between MeDi and outcomes with linear regression models controlling for several covariates. In addition, we applied hypothesis-driven mediation and moderation analysis.

Results

Higher MeDi adherence related to larger mediotemporal gray matter volume (p < 0.05 family-wise error corrected), better memory (β ± SE = 0.03 ± 0.02; p = 0.038), and less amyloid (Aβ42/40 ratio, β ± SE = 0.003 ± 0.001; p = 0.008) and pTau181 (β ± SE = −1.96 ± 0.68; p = 0.004) pathology. Mediotemporal volume mediated the association between MeDi and memory (40% indirect mediation). Finally, MeDi favorably moderated the associations among Aβ42/40 ratio, pTau181, and mediotemporal atrophy. Results were consistent correcting for APOE-ε4 status.

Conclusion

Our findings corroborate the view of MeDi as a protective factor against memory decline and mediotemporal atrophy. They suggest that these associations might be explained by a decrease of amyloidosis and tau pathology. Longitudinal and dietary intervention studies should further examine this conjecture and its treatment implications.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

References

1.
Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921.
Crossref
PubMed
Google Scholar
2.
Lourida I, Soni M, Thompson-Coon J, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. 2013;24(4):479-489.
Crossref
PubMed
Google Scholar
3.
Petersson SD, Philippou E. Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr. 2016;7(5):889-904.
Crossref
PubMed
Google Scholar
4.
Sofi F, Cesari F, Abbate R, Franco Gensini G, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337:a1344.
Crossref
PubMed
Google Scholar
5.
Akbaraly T, Sexton C, Zsoldos E, et al. Association of long-term diet quality with hippocampal volume: longitudinal cohort study. Am J Med. 2018;131(11):1372-1381.e4.
Crossref
PubMed
Google Scholar
6.
Psaltopoulou T, Kyrozis A, Stathopoulos P, Trichopoulos D, Vassilopoulos D, Trichopoulou A. Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation Into Cancer and Nutrition). Public Health Nutr. 2008;11(10):1054-1062.
Crossref
PubMed
Google Scholar
7.
Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094-1103.
Crossref
PubMed
Google Scholar
8.
Martínez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging. 2013;17(6):544-552.
Crossref
PubMed
Google Scholar
9.
Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271-282.
Crossref
PubMed
Google Scholar
10.
Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66(2):216-225.
Crossref
PubMed
Google Scholar
11.
Matthews DC, Davies M, Murray J, et al. Physical activity, Mediterranean diet and biomarkers-assessed risk of Alzheimer's: a multi-modality brain imaging study. Adv J Mol Imaging. 2014;4(4):43-57.
Crossref
PubMed
Google Scholar
12.
Mosconi L, Murray J, Tsui WH, et al. Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively normal individuals at risk for Alzheimer's disease. J Prev Alzheimers Dis. 2014;1(1):23-32.
PubMed
Google Scholar
13.
Staubo SC, Aakre JA, Vemuri P, et al. Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement. 2017;13(2):168-177.
Crossref
PubMed
Google Scholar
14.
Gu Y, Brickman AM, Stern Y, et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology. 2015;85(20):1744-1751.
Crossref
PubMed
Google Scholar
15.
Karstens AJ, Tussing-Humphreys L, Zhan L, et al. Associations of the Mediterranean diet with cognitive and neuroimaging phenotypes of dementia in healthy older adults. Am J Clin Nutr. 2019;109(2):361-368.
Crossref
PubMed
Google Scholar
16.
Vassilaki M, Aakre JA, Syrjanen JA, et al. Mediterranean diet, its components, and amyloid imaging biomarkers. J Alzheimers Dis. 2018;64(1):281-290.
Crossref
PubMed
Google Scholar
17.
Berti V, Walters M, Sterling J, et al. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Neurology. 2018;90(20):e1789–e1798.
Crossref
PubMed
Google Scholar
18.
Hill E, Szoeke C, Dennerstein L, Campbell S, Clifton P. Adherence to the Mediterranean diet is not related to beta-amyloid deposition: data from the Women's Healthy Ageing Project. J Prev Alzheimers Dis. 2018;5(4):137-141.
PubMed
Google Scholar
19.
Merrill DA, Siddarth P, Raji CA, et al. Modifiable risk factors and brain positron emission tomography measures of amyloid and tau in nondemented adults with memory complaints. Am J Geriatr Psychiatry. 2016;24(9):729-737.
Crossref
PubMed
Google Scholar
20.
Rainey-Smith SR, Gu Y, Gardener SL, et al. Mediterranean diet adherence and rate of cerebral aβ-amyloid accumulation: data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Transl Psychiatry. 2018;8(1):238.
Crossref
PubMed
Google Scholar
21.
Jessen F, Spottke A, Boecker H, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Alzheimers Res Ther. 2018;10(1):15.
Crossref
PubMed
Google Scholar
22.
Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10(6):844-852.
Crossref
PubMed
Google Scholar
23.
Molinuevo JL, Rabin LA, Amariglio R, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13(3):296-311.
Crossref
PubMed
Google Scholar
24.
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270-279.
Crossref
PubMed
Google Scholar
25.
Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46(2):153-162.
Crossref
PubMed
Google Scholar
26.
Wolfsgruber S, Kleineidam L, Guski J, et al. Minor neuropsychological deficits in patients with subjective cognitive decline. Neurology. 2020;95(9):e1134-e1143.
Crossref
PubMed
Google Scholar
27.
Noethlings U, Hoffmann K, Bergmann MM, Boeing H. Portion size adds limited information on variance in food intake of participants in the EPIC-Potsdam study. J Nutr. 2003;133(2):510-515.
Crossref
PubMed
Google Scholar
28.
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599-2608.
Crossref
PubMed
Google Scholar
29.
Wiltfang J, Esselmann H, Bibl M, et al. Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-tau in patients with low- and high-CSF A beta 40 load. J Neurochem. 2007;101(4):1053-1059.
Crossref
PubMed
Google Scholar
30.
Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage. 2000;11(6):805-821.
Crossref
PubMed
Google Scholar
31.
Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271-278.
Crossref
PubMed
Google Scholar
32.
Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016;8(6):595-608.
Crossref
PubMed
Google Scholar
33.
Stern Y, Arenaza-Urquijo EM, Bartrés-Faz D, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16(9):1305-1311.
Crossref
PubMed
Google Scholar
34.
Pelletier A, Barul C, Féart C, et al. Mediterranean diet and preserved brain structural connectivity in older subjects. Alzheimers Dement. 2015;11(9):1023-1031.
Crossref
PubMed
Google Scholar
35.
Titova OE, Ax E, Brooks SJ, et al. Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes. Exp Gerontol. 2013;48(12):1443-1448.
Crossref
PubMed
Google Scholar
36.
Wesselman LMP, Melo van Lent D, Schröder A, et al. Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk for Alzheimer's disease. Eur J Nutr. 2021;60(2):849-860.
Crossref
PubMed
Google Scholar
37.
Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PLoS One. 2017;12(8):e0182048.
Crossref
PubMed
Google Scholar
38.
Loughrey DG, Lavecchia S, Brennan S, Lawlor BA, Kelly ME. The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. Adv Nutr. 2017;8(4):571-586.
Crossref
PubMed
Google Scholar
39.
Samieri C, Grodstein F, Rosner BA, et al. Mediterranean diet and cognitive function in older age. Epidemiology. 2013;24(4):490-499.
Crossref
PubMed
Google Scholar
40.
Su Kwak S, Washicosky KJ, Brand E, et al. Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease. Nat Commun. 2020;11(1):1-14.
PubMed
Google Scholar
41.
Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement. 2018;4:575-590.
Crossref
Google Scholar
42.
Tosti V, Bertozzi B, Fontana L. Health benefits of the Mediterranean diet: metabolic and molecular mechanisms. J Gerontol A Biol Sci Med Sci. 2018;73(3):318-326.
Crossref
PubMed
Google Scholar
43.
Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimers Dis. 2017;57(4):1105-1121.
Crossref
PubMed
Google Scholar
44.
Qosa H, Mohamed LA, Batarseh YS, et al. Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice. J Nutr Biochem. 2015;26(12):1479-1490.
Crossref
PubMed
Google Scholar
45.
Scarmeas N, Luchsinger JA, Schupf N, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA. 2009;302(6):627-637.
Crossref
PubMed
Google Scholar
46.
Wagner M, Grodstein F, Proust-Lima C, Samieri C. Long-term trajectories of body weight, diet, and physical activity from midlife through late life and subsequent cognitive decline in women. Am J Epidemiol. 2020;189(4):305-313.
Crossref
PubMed
Google Scholar
47.
Jin Q, Black A, Kales SN, Vattem D, Ruiz-Canela M, Sotos-Prieto M. Metabolomics and microbiomes as potential tools to evaluate the effects of the Mediterranean diet. Nutrients. 2019;11(1):207.
Crossref
PubMed
Google Scholar
48.
Barabási AL, Menichetti G, Joseph L. The unmapped chemical complexity of our diet. Nat Food. 2020;1:33-37.
Crossref
Google Scholar
49.
van de Rest O, Am Berendsen A, Haveman-Nies A, de Groot LC. Dietary patterns, cognitive decline, and dementia: a systematic review. Adv Nutr. 2015;6(2):154-168.
Crossref
PubMed
Google Scholar
50.
Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30-43.
Crossref
PubMed
Google Scholar
Letters to the Editor
25 September 2021
Author Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age
Tommaso Ballarini, Post doctoral fellow| German Center for Neurodegenerative Diseases (DZNE), Bonn, DE
Debora Melo van Lent, Post doctoral fellow| Biggs Alzheimer's Institute, University of Texas Health Science Center at San Antonio: San Antonio, TX, US
Michael Wagner, Professor| German Center for Neurodegenerative Diseases (DZNE) & University Hospital Bonn, Bonn, DE

We thank Dr. Brenner for the insightful comment on our article.1 We agree that in the context of a Mediterranean diet, several bioactive compounds—including spermidine—are highly interesting for preventing neurodegeneration and dementia. For example, this hypothesis could be further clarified in intervention studies with spermidine supplementation.2 Notable results have been recently provided by the LipiDiDiet clinical trial showing how an early and prolonged multi-nutrient intervention slowed the decline on cognitive and brain outcomes in the prodromal Alzheimer stages.3

However, as of yet the majority of intervention studies based on nutrient supplementation showed insufficient efficacy for preventing cognitive decline and dementia.4 For the moment, we believe that dietary recommendations for public health purposes should not focus on specific nutrients but rather on dietary patterns that better summarize the dynamic interplay between foods and their constituents. This might rapidly change due to forthcoming studies and the availability of novel technologies or analytical techniques that will allow mapping of the complexity of food. This topic has been elegantly exposed by Barabasi et al., who assert that our diet comprises several thousand biochemical compounds with potential, but still largely unknown effects on health and disease.5

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Ballarini T, Melo van Lent D, Brunner J, et al. Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age [published online ahead of print, 2021 May 5]. Neurology. 2021;96(24):e2920-e2932. doi:10.1212/WNL.0000000000012067
  2. Wirth M, Schwarz C, Benson G, et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol for a randomized controlled trial. Alzheimers Res Ther. 2019;11(1):36. Published 2019 May 1. doi:10.1186/s13195-019-0484-1
  3. Soininen H, Solomon A, Visser PJ, et al. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease [published correction appears in Alzheimers Dement. 2021 May;17(5):909]. Alzheimers Dement. 2021;17(1):29-40. doi:10.1002/alz.12172
  4. Rutjes AW, Denton DA, Di Nisio M, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. Cochrane Database Syst Rev. 2018;12(12):CD011906. Published 2018 Dec 17. doi:10.1002/14651858.CD011906.pub2
  5. Barabási, AL., Menichetti, G. & Loscalzo, J. The unmapped chemical complexity of our diet. Nat Food 1, 33–37 (2020). https://doi.org/10.1038/s43016-019-0005-1
27 June 2021
Reader Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age
Steven R Brenner, Neurologist (retired)| Saint Louis University Neurology Department

I read the study by Ballarini et al. with interest, which details the Mediterranean diet (MD) as being protective against memory decline and mediotemporal atrophy, especially with reference to the decrease of amyloidosis and tau pathology.1

A similar dietary study of older adults with subjective cognitive decline (SCD) and healthy controls (HC) indicated higher dietary spermidine content of food mediated the effects of adherence to a MD. The study revealed MRI-measured larger hippocampal volume, greater mean cortical thickness, and greater cortical thickness in regions vulnerable to Alzheimer Disease (AD)—including parietal and temporal regions—irrespective of SCD and HC.2

Age-related Amyloid Beta (A-Beta) and Phosphorylated tau (P-tau) lead to dysfunctional autophagy (AP) and mitophagy (MP), which are important for continuous removal of cellular debris and damaged mitochondria.3 Enhancing AP and MP may be achieved through bioactive food compounds common in the MD and other cultural diets, which are rich in fish, vegetables, fruit, whole grains, and extra-virgin olive oil, including curcumin, astaxanthin, oleuropein, hydroxytyrosol, resveratrol and spermidine.4

A spermidine supplementation trial resulted in improved cognitive function in patients with mild or moderate loss of cognition symptoms.5 As such, bioactive food compounds in the MD may enhance cognitive function and prevent brain atrophy.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Ballarini T, Melo van Lent D, Brunner J, et al. Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age [published online ahead of print, 2021 May 5]. Neurology. 2021;96(24):e2920-e2932. doi:10.1212/WNL.0000000000012067
  2. Schwarz C, Horn N, Benson G, et al. Spermidine intake is associated with cortical thickness and hippocampal volume in older adults. Neuroimage. 2020;221:117132. doi:10.1016/j.neuroimage.2020.117132
  3. Reddy PH, Oliver DM. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Cells. 2019;8(5):488. Published 2019 May 22. doi:10.3390/cells8050488
  4. Varghese N, Werner S, Grimm A, Eckert A. Dietary Mitophagy Enhancer: A Strategy for Healthy Brain Aging?. Antioxidants (Basel). 2020;9(10):932. Published 2020 Sep 29. doi:10.3390/antiox9100932
  5. Pekar T, Bruckner K, Pauschenwein-Frantsich S, et al. The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial. Wien Klin Wochenschr. 2021;133(9-10):484-491. doi:10.1007/s00508-020-01758-y

Information & Authors

Information

Published In

Neurology®
Volume 96 • Number 24 • June 15, 2021
Pages: e2920-e2932
PubMed: 33952652

Copyright

© 2021 American Academy of Neurology.

Publication History

Received: August 6, 2020
Accepted: March 15, 2021
Published online: May 5, 2021
Published in print: June 15, 2021

Permissions

Request permissions for this article.

Disclosure

T. Ballarini, D. Melo van Lent, J. Brunner, A. Schröder, S. Wolfsgruber, S. Altenstein, F. Brosseron, K. Buerger, P. Dechent, L. Dobisch, E. Düzel, B. Ertl-Wagner, K. Fliessbach, S. Dawn Freiesleben, I. Frommann, W. Glanz, D. Hauser, J. D. Haynes, M. T. Heneka, D. Janowitz, I. Kilimann, C. Laske, F. Maier, C. D. Metzger, M. H. Munk, R. Perneczky, and O. Peters report no disclosures relevant to the manuscript; J. Priller received fees for consultation, lectures, and patents from Neurimmune, Axon, Desitin, and Epomedics. A. Ramirez, B. Rauchmann, N. Roy, K. Scheffler, A. Schneider, A. Spottke, E. J. Spruth, S. Teipel, R. Vukovich, and J. Wiltfang report no disclosures relevant to the manuscript; F. Jessen received fees for consultation from Eli Lilly, Novartis, Roche, BioGene, MSD, Piramal, Janssen, and Lundbeck. M. Wagner reports no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Study Funding

Study funded by the German Center for Neurodegenerative Diseases (Deutsches zentrum für Neurodegenerative Erkrankungen [DZNE]) and by the Diet Body Brain research cluster funded by the German Federal Ministry of Education and Research (grant 01EA1809C).

Authors

Affiliations & Disclosures

Tommaso Ballarini, PhD https://orcid.org/0000-0001-7299-5973
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Debora Melo van Lent, PhD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH,5R03AG067062-02, PI, 2020-current
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
ASPEN Rhoads Research foundation, PI, 2019-current
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Julia Brunner, MSc
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Alina Schröder, MSc
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Steffen Wolfsgruber, PhD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Journal of Alzheimer's Diseases, Associate Editior, 2 years
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Slawek Altenstein, Dipl-Psych
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
employee of the Charité, University Medicine Berlin and the German Center for Neurodegenerative Diseases e.V.
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Frederic Brosseron, PhD https://orcid.org/0000-0003-3137-7516
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Katharina Buerger, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
(1) Biogen GmbH Germany: Advisory Board on Aducanumab
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
(1)German Center for Neurodegenerative Diseases (DZNE)
Research Support, Foundations and Societies:
1.
(1) Legerlotz Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Peter Dechent, PhD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Laura Dobisch, MSc
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Emrah Düzel, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
Biogen, RoX Health
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Biogen, Honoraria for talk
Editorial Boards:
1.
Action Editor Cortex Editorial Board Neuroimage Clinical
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) German Research Council CRC 1315, TPB06 (2) BMBF EnergI-Consortium (3) German Research Council CRC 1436, TPB02 (4) European Union’s Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 945539 (Human Brain Project SGA3).
Stock/stock Options/board of Directors Compensation:
1.
I am co-founder of the company
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Birgit Ertl-Wagner, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
1. Deputy Editor Radiology, since 2016 2. Associate Editor AJNR, since 2020 3. Associate Editor Neuroradiology, since 2017
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
My husband is an employee of Siemens Healthineers, General Manager Medicalis, since 2019
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Klaus Fliessbach, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Silka Dawn Freiesleben, MSc
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Ingo Frommann, Dipl-Psych https://orcid.org/0000-0002-7244-2014
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Wenzel Glanz, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Dietmar Hauser, Dipl-Psych
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
(1)DZNE, Research assistant, 2017-2020
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
John Dylan Haynes, PhD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Michael T. Heneka, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
Michael T. Heneka serves as an scientific advisory board member for Tiaki, Alector and IFM Therapeutics.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Journal of Neurochemistry, Editorial Board Member (since 2010-2015), Journal of Chemical Neuroanatomy, Editorial Board Member (since 2008-2015), Molecular Neurobiology (Editorial Board, 2012-ongoing) Neurology, Neuroimmunology&Neuroinflammation, Associate Editor
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
DFG KFO177, Project 8 (www.kfo177.de)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Daniel Janowitz, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Funding for travel 2018,Pfizer GmbH
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Ingo Kilimann, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
Clinical Dementia Research, German Center for Neurodegenerative Disease (DZNE)Rostock/Greifswald, imaging studies 40%
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
German ministry of economic cooperation and development, 17.2170.3-004.02
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Christoph Laske, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Franziska Maier, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Coraline Danielle Metzger, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Matthias H. Munk, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Robert Perneczky, MD https://orcid.org/0000-0003-1981-7435
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Oliver Peters, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
(1) Roche, (2) Biogen
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Schwabe, speaker honorar
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1)Eli Lilly, (2)Lundbeck, (3)Genentech, (4) Biogen, (4) Roche, (5) Pharmatrophix, (6) Novartis, (7) Janssen, (8) Probiodrug
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Josef Priller, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
(1) Axon
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Axon (2) CHDI (3) UK DRI
Editorial Boards:
1.
Brain Commun, associate Editor Glia, member of Editorial board Cytotherapy,member of Editorial board Brain Pathology, member of Editorial board Plos One, member of Editorial board
Patents:
1.
Licensed to Epomedics.
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Founder, Vapumed
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
DFG BMBF UK DRI
Research Support, Academic Entities:
1.
University of Edinburgh, UK
Research Support, Foundations and Societies:
1.
MS Society
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
Epomedics
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Alfredo Ramirez, MD https://orcid.org/0000-0003-4991-763X
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Honorary received for services as expert and speaker of the Scientific advisory board on the topic of Dementia with Lewy body organized by GE-health care.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Boris-Stephan Rauchmann, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Nina Roy, PhD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Klaus Scheffler, PhD https://orcid.org/0000-0001-6316-8773
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
I design helicopters
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Anja Schneider, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
(1) DSM: non-profit entity, Vorinostat Phase Ib trial, IIT (2) Scientific advisory board, non- profit entity: MAVO Brain lab (3) Scientific advisory board, German PSP Society
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Commercial (travel costs&accomodation): Novartis (2) Commercial (travel costs&accomodation): Diagnostik Netz BB
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Actelion, research grant on exosomal cholesterol in Niemann-Pick type c
Research Support, Government Entities:
1.
German Research Foundation European Union BMBF
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Helmholtz Foundation Michael J Fox Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Annika Spottke, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Eike Jakob Spruth, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Employment at the Charité - University Medicine Berlin since 2000 as a physician and scientist
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Stefan J. Teipel, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
ROCHE Pharma AG, Emil-Barell-Str. 1, 79639 Grenzach- Wyhlen, Switzerland MSD Sharp & Dohme GmbH, Lindenplatz 1, 85540 Haar, Germany Biogen GmbH, Riedenburger Str. 7, 81677 München, Germany
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
MSD Sharp & Dohme GmbH Quality circle for physicians in Kühlungsborn, Talk: „Dementia and Diabetes – current report“ Talk on
Editorial Boards:
1.
Alzheimer's and Dementia, Associate Editor, 7 years DADM Senior Editor, 4 years
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) ROCHE, Roche Pharma AG, Grenzach, Phase III trial (2) Lilly Deutschland GmbH, Observational Study (3) Böhringer-Ingelheim Pharma GmbH & Co. KG, Germany,Observational Study (4) Molecular Life Imaging, Germany, Observational Study (5) Fujifilm Toyama Chemical, Phase III trial
Research Support, Government Entities:
1.
(1) Federal Ministry of Research (BMBF), SiNDeM, FKZ: 16SV7091, co-investigator, 2014-2015 (2) Federal Ministry of Research (BMBF), InsideDem, FKZ: V4PID011, co-investigator, 2015-2018 (3) Ministry of Economics of the State Mecklenburg Western Pomerania, SAMi, co-investigator, 2018 -2020 (4) Federal Ministry of Research (BMBF), AgeGain, FKZ: 01GQ1425B, co-investigator, 2015-2019
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Ruth Vukovich, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Jens Wiltfang, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
(1) Advisory Board for Eli Lilly (European Alzheimer's Advisory Board (2) Advisory Board for MSD SHARP & DOHME (MK-8931/ Verubecestat (3) Advisory Board for Roche Pharma (4) Advisory Board Biogen (5) Advisory Board Abbott (6) Advisory Board Immungenetics (7) Advisory Board Boehringer Ingelheim
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Eli Lilly Advisory Board: honorarium and support for travelling to Board meetings (2) Pfizer: honorarium for lectures (3) Janssen: honorarium for lectures (4) MSD SHARP & DOHME Advisory Board: honorarium and support for travelling to Board Meetings (5) medUpdate GmbH: honorarium for lectures and travelling Support (6) Amgen: honorarium for lectures (7) Roche Pharma: honorarium for lectures (8) Actelion Pharmaceuticals: honorarium for lectures (9) Guangzhou Glorylen Medical Technology Co. (China), Bejing Yibai Science and Technology Ltd.: honorarium for lectures
Editorial Boards:
1.
NONE
Patents:
1.
(1)Patent no.: EP1270592B1, Monoclonal Antibody 1E8 against N-terminal Abeta-Peptid (2)Patent no.: US 6,849,416 B2, Monoclonal Antibody 1E8 against N-terminal Abeta-Peptid (3)Patent no.: EP2095128B1, Method of differentially diagnosing dementias (4)Patent no.: EP3105589A1, Biosensor for conformation and secondary structure analysis
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1) Consultant for Boehringer-Ingelheim (2) Consultant for F. Hoffmann-La Roche (3) Consultant for Biogen (4) Consultant for Immungenetics (5) Consultant for Abbott
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Frank Jessen, MD
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
Commercial: Biogen, Roche, AC Immune, Janssen Cilag, Esai, Vifor, Abbvie
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Roche, Biogen, Janssen
Editorial Boards:
1.
Journal of Alzheimer's disease, Journal of Prevention of Alzheimer's disease, Alzheimer's Research and Therapy
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Michael Wagner, PhD https://orcid.org/0000-0003-2589-6440
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
German Ministry of Education and Research (BMBF), grant 01EA1809C (DietBodyBrain)
Research Support, Academic Entities:
1.
University of Bonn, Department of Neurodegenerative Diseases and Geriatric Psychiatry
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
on behalf of the DELCODE Study Group
From the German Center for Neurodegenerative Diseases (DZNE) (T.B., D.M.v.L., J.B., A.Schröder, S.W., F.B., K.F., I.F., M.T.H., N.R., A. Schneider, A. Spottke, F.J., M.W.), Bonn, Venusberg-Campus 1, Bonn, Germany; University of Texas Health Science Center at San Antonio (D.M.v.L.); Department of Neurodegeneration and Geriatric Psychiatry (S.W., F.B., K.F., M.T.H., A. Schneider, M.W.), University Hospital Bonn, Venusberg-Campus 1; German Center for Neurodegenerative Diseases (DZNE) (S.A., O.P., J.P., E.J.S.); Department of Psychiatry and Psychotherapy (S.A., J.P., E.J.S.), Charité, Charitéplatz 1, Berlin; German Center for Neurodegenerative Diseases (DZNE, Munich) (K.B., R.P.); Institute for Stroke and Dementia Research (ISD) (K.B.), University Hospital, LMU Munich; MR-Research in Neurology and Psychiatry (P.D.), Georg-August University Göttingen; German Center for Neurodegenerative Diseases (DZNE) (L.D., E.D., W.G., C.D.M.); Institute of Cognitive Neurology and Dementia Research (IKND) (L.D., E.D., C.D.M.), Otto-von-Guericke University, Magdeburg; Institute for Clinical Radiology (B.E.-W.), Ludwig-Maximilians-University, Munich; Charité Universitätsmedizin Berlin (S.D.F., D.H., O.P.), Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin; Bernstein Center for Computational Neuroscience (J.D.H.), Charité Universitätsmedizin, Berlin; Institute for Stroke and Dementia Research (ISD) (D.J.), University Hospital, LMU Munich; German Center for Neurodegenerative Diseases (DZNE) (I.K., S.J.T.); Department of Psychosomatic Medicine (I.K., S.J.T.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (C.L., M.H.M.); Section for Dementia Research (C.L., M.H.M.), Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen; Department of Psychiatry (F.M., A.R., F.J.), University of Cologne, Medical Faculty; Department of Psychiatry and Psychotherapy (R.P., B.R.), University Hospital, LMU Munich; Munich Cluster for Systems Neurology (SyNergy) (R.P.) Munich, Germany; Ageing Epidemiology Research Unit (AGE) (R.P.), School of Public Health, Imperial College London, UK; Department for Biomedical Magnetic Resonance (K.S.), University of Tübingen; Department of Neurology (A. Spottke), University of Bonn, Venusberg-Campus 1; Department of Psychiatry and Psychotherapy (R.V., J.W.), University Medical Center Goettingen, University of Goettingen; German Center for Neurodegenerative Diseases (DZNE) (J.W.), Goettingen, Germany; Neurosciences and Signaling Group (J.W.), Institute of Biomedicine (iBiMED); Department of Medical Sciences (J.W.), University of Aveiro, Portugal; and Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) (F.J.), University of Cologne, Germany.
View all articles by this author

Notes

Correspondence Dr. Ballarini [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Coinvestigators are listed at links.lww.com/WNL/B405.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • Cuicui Li,
    • Honghong Ren,
    • Hongzhu Liu,
    • Tong Li,
    • Yigang Liu,
    • Baolin Wu,
    • Ke Han,
    • Shuqi Zang,
    • Guoqing Zhao,
    • Ximing Wang,
    Middle frontal gyrus volume mediates the relationship between interleukin-1β and antidepressant response in major depressive disorder, Journal of Affective Disorders, 372, (56-65), (2025).https://doi.org/10.1016/j.jad.2024.11.070
    Crossref
    • Alexandra L. Clark,
    • Abbey M. Hamlin,
    • Nazareth Ortega,
    • Jordana Breton,
    Social and structural determinants of cognitive and brain aging outcomes in racially/ethnically minoritized older adults, Encyclopedia of the Human Brain, (161-174), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00181-9
    Crossref
    • Qilin Yuan,
    • Ying Han,
    • Shuangfang Fang,
    • Hanhan Lei,
    • Huapin Huang,
    • Huiying Lin,
    • Xiaomin Wu,
    • Ronghua Chen,
    • Zhiting Chen,
    • Jie Chen,
    • Hangfeng Li,
    • Nan Liu,
    • Houwei Du,
    Sex difference in the association between triglyceride and intracerebral bleeding risk after intravenous thrombolysis for acute ischemic stroke, a multi-center retrospective study, PeerJ, 12, (e17558), (2024).https://doi.org/10.7717/peerj.17558
    Crossref
    • Semra Akar Sahingoz,
    • Güldağ Herdem,
    Mediterranean Diet and Health, Well-Being Across the Globe - New Perspectives, Concepts, Correlates and Geography, (2024).https://doi.org/10.5772/intechopen.104257
    Crossref
    • Д.Р. Турсуметова,
    • Ю. Хан,
    • Л.В. Ткачёва,
    • К.П. Раевский,
    РОЛЬ И ОСОБЕННОСТИ МИКРОБИОТЫ КИШЕЧНИКА ПРИ БОЛЕЗНИ АЛЬЦГЕЙМЕРА, Успехи геронтологии, 37, 4, (442-452), (2024).https://doi.org/10.34922/AE.2024.37.4.016
    Crossref
    • Ayako Nakaki,
    • Yvan Gomez,
    • Sara Castro-Barquero,
    • Allegra Conti,
    • Kilian Vellvé,
    • Irene Casas,
    • Mariona Genero,
    • Lina Youssef,
    • Laura Segalés,
    • Leticia Benitez,
    • Rosa Casas,
    • Eduard Vieta,
    • Nuria Bargallo,
    • Nicola Toschi,
    • Ramon Estruch,
    • Fàtima Crispi,
    • Eduard Gratacos,
    • Francesca Crovetto,
    The Mediterranean Diet in Pregnancy: Implications for Maternal Brain Morphometry in a Secondary Analysis of the IMPACT BCN Randomized Clinical Trial, Nutrients, 16, 11, (1604), (2024).https://doi.org/10.3390/nu16111604
    Crossref
    • Israel Contador,
    • Bárbara Buch-Vicente,
    • Teodoro del Ser,
    • Sara Llamas-Velasco,
    • Alberto Villarejo-Galende,
    • Julián Benito-León,
    • Félix Bermejo-Pareja,
    Charting Alzheimer’s Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways, Journal of Clinical Medicine, 13, 14, (4100), (2024).https://doi.org/10.3390/jcm13144100
    Crossref
    • Adolfo Toledano,
    • Arantxa Rodríguez-Casado,
    • María Isabel Älvarez,
    • Adolfo Toledano-Díaz,
    Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models), Brain Sciences, 14, 11, (1101), (2024).https://doi.org/10.3390/brainsci14111101
    Crossref
    • João Victor Laurindo dos Santos,
    • Ingrid Sofia Vieira de Melo,
    • Clara Andrezza Crisóstomo Bezerra Costa,
    • Layanne Cabral de Almeida,
    • Dafiny Rodrigues Silva,
    • Débora Cavalcante Ferro,
    • Déborah Tenório Costa Paula,
    • Mateus de Lima Macena,
    • Nassib Bezerra Bueno,
    Association Between Ultra-Processed Food Consumption and Cognitive Performance Among Adolescent Students From Underdeveloped Cities in Brazil: A Cross-Sectional Study, International Journal of Public Health, 69, (2024).https://doi.org/10.3389/ijph.2024.1607658
    Crossref
    • Efstratios Karavasilis,
    • Vasileios Balomenos,
    • Foteini Christidi,
    • Georgios Velonakis,
    • Georgia Angelopoulou,
    • Mary Yannakoulia,
    • Eirini Mamalaki,
    • Archontoula Drouka,
    • Dora Brikou,
    • Angeliki Tsapanou,
    • Yian Gu,
    • Nikolaos Scarmeas,
    Mediterranean diet and brain functional connectivity in a population without dementia, Frontiers in Neuroimaging, 3, (2024).https://doi.org/10.3389/fnimg.2024.1473399
    Crossref
  11. See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

View Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share

View full text|Download PDF